FUSEN PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.89 HKD | +3.49% |
|
0.00% | -35.04% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 492M 68.06M 532M | Sales 2023 | 566M 78.28M 612M | Capitalization | 928M 128M 1B |
|---|---|---|---|---|---|
| Net income 2022 | -34M -4.71M -36.76M | Net income 2023 | -36M -4.98M -38.93M | EV / Sales 2022 | 2.15 x |
| Net Debt 2022 | 100M 13.88M 108M | Net Debt 2023 | 314M 43.44M 339M | EV / Sales 2023 | 2.2 x |
| P/E ratio 2022 |
-25.3
x | P/E ratio 2023 |
-24.9
x | Employees | 1,148 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.23% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.49% | ||
| 1 month | -1.11% | ||
| 3 months | -33.58% | ||
| 6 months | -38.19% | ||
| Current year | -35.04% |
1 week
0.82
0.89
1 month
0.761.00
Current year
0.761.39
1 year
0.761.60
3 years
0.764.34
5 years
0.7620.00
10 years
0.7620.00
| Managers | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 46 | 19-04-17 |
Zhi Ming Cao
BRD | Director/Board Member | 38 | 13-01-17 |
Tik Man Wong
SEC | Corporate Secretary | 43 | 21-01-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kwok Tung Lee
BRD | Director/Board Member | 56 | 19-04-14 |
Chang Cheng Cao
CHM | Chairman | 67 | 16-11-19 |
Tai Sheng Hou
BRD | Director/Board Member | 61 | 17-04-06 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.89 | +3.49% | 505,000 |
| 24-05-09 | 0.86 | 0.00% | 117,000 |
| 24-05-08 | 0.86 | 0.00% | 158,000 |
| 24-05-07 | 0.86 | -2.27% | 116,000 |
| 24-05-06 | 0.88 | 0.00% | 331,000 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT
More quotes
Fusen Pharmaceutical Co Ltd is a China-based company principally engaged in the provision of Shuanghuanglian series cold medicines. The Company is mainly engaged in research, development, production and sales of Chinese patent drugs and western medicine products for the treatment of cold and fever, cardiovascular diseases and anemia. The Company's main products include small volume injections, oral liquids, tablets, capsules and granules. The Company distributes its products mainly in domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -35.04% | 84.21M | |
| +19.62% | 43.27B | |
| +24.52% | 22.92B | |
| +20.29% | 15.43B | |
| +7.48% | 12.95B | |
| +42.51% | 11.83B | |
| -8.84% | 6.91B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.55B |
- Stock Market
- Equities
- 1652 Stock